Form 4 for EDIT Editas Medicine, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0001650664-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-04 | EDIT | Mei Baisong | SVP, Chief MEDICAL Off | S - Sale | $9.42 | -20.3K | 141.5K | -13% | -$191.5K |
| DM | 2024-03-05 | 2024-03-02 | EDIT | Mei Baisong | SVP, Chief MEDICAL Off | A - Grant | $0.00 | +89.8K | 142.4K | +171% | $0 |
| D | 2024-03-05 | 2024-03-02 | EDIT | Mei Baisong | SVP, Chief MEDICAL Off | A - Grant | $0.00 | +152.8K | 152.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | S | D | 20,327 | $9.42 | 141,543 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-03-02 | A | A | 50,900 | $0.00 | 122,955 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-02 | A | A | 19,457 | $0.00 | 161,870 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-02 | A | A | 19,458 | $0.00 | 142,413 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2024-03-02 | A | A | 152,800 | $0.00 | 152,800 | D | $10.53 · — to 2034-03-01 | 152,800 Common Stock | (F6) This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2024 through March 2, 2028. |